Overall rank by patents
#41,554
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 1 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01K (ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS).
The verdict
Megabass holds 6 US patents across 1 technology areas, rank #41,554 of 50,000 tracked assignees.
Megabass, Inc has been granted 6 US utility patents between 2021 and 2025, placing Megabass, Inc at rank #41,554 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.8 claims per patent with primary concentration in A01K (ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS). As a Foreign Corporation, Megabass, Inc is one of the more focused assignees in the PatentsView dataset. By volume, Megabass sits between Medrelief Inc. (6 patents, rank #41,550) and Melodea Ltd. (6 patents, rank #41,558) - the closest US assignees by grant volume. The composite Innovation Score of 15.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Megabass, Inc's 1.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Megabass, Inc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MEDRELIEF INC.
6 patents
MEDSAPIENS CO., LTD.
6 patents
MEDSTREAMING, INC.
6 patents
MEGA SLAM HOOPS, LLC
6 patents
MEIJO NANO CARBON CO., LTD.
6 patents
MEISHAN CRRC FASTENING SYSTEM CO., LTD
6 patents
MELBOURNE HEALTH
6 patents
MELODEA LTD.
6 patents
MEGABASS, INC
6 patents
What this shows Megabass holds 6 patents at rank #41,554, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #41,554 in granted patent volume.
Other assignees with the most granted patents in Megabass's primary technology class.
Megabass's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
16 Top 97% higher than 3% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 3 | 50.0% |
| 2023 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
| 2025 | 1 | 16.7% |
Top 1 of 1 technology areas
Overall rank by patents
#41,554
Across all tracked assignees
15.8 out of 100
How to use this portfolio
Megabass's 6 grants land it in the top 97% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.